Virios Therapeutics (VIRI) Reports Q2 Loss of $0.51/sh
Virios Therapeutics (NASDAQ: VIRI) reported Q2 EPS of ($0.51), versus ($0.14) reported last year.
For earnings history and earnings-related data on Virios Therapeutics (VIRI) click here.
Virios Therapeutics (NASDAQ: VIRI) reported Q2 EPS of ($0.51), versus ($0.14) reported last year.
For earnings history and earnings-related data on Virios Therapeutics (VIRI) click here.